baber/WOPTO huggingface dataset:
Patent NZ-320174-A (NZ)
Title: 4a,5a,8a,8b-tetrahydro-6H-pyrrolo[3,4':4,5]furo(3,2-b)pyridine-6,8-[7H]- dione derivatives useful for controlling endoparasites
Inventor: JESCHKE PETER
IPC: C07D491/147
Filed: 1996-10-07
Abstract: The 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyridine-6,8(7H)-dione derivatives or salts, optical isomers and racemates thereof have the formula (I) wherein: R1 is hydrogen, alkyl, cycloalkyl, arylalkyl, aryl, heteroaryl or  heteroarylalkyl which are optionally substituted; R2 and R3 independently of one another are hydrogen, alkyl, halogenoalkyl, hydroxyalkyl, alkanoyloxyalkyl, alkoxyalkyl, mercaptoalkyl, alkylthioalkyl, alkylsulphinylalkyl, alkylsulphonylalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, cycloalkylaminoalkyl, cycloalkyl or alkoxycarbonyl; R4 is hydrogen, alkyl, halogenoalkyl, hydroxyalkyl, alkanoyloxyalkyl, alkoxyalkyl, alkoxycarbonylalkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, trialkylammoniumalkyl halide, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, amino, alkylamino, dialkylamino or cycloalkylamino, which are optionally substituted; R5 is hydrogen and provided when: R1 is hydrogen, R2 and R3 are methyl, then R4 is other than methyl, n-butyl, phenyl, 2-, 3- or 4-methylphenyl, 2-, 3- or 4-chlorophenyl, 2-, 3- or 4-fluorophenyl, 2-chloro-4-fluorophenyl, 2-fluoro-4-chlorophenyl, 3-chloro- 4-fluorophenyl, 2-, 3-, 4-nitrophenyl, 4-methoxyphenyl or naphthyl. The compounds are useful as endoparasiticidal agents.
Patent NZ-320687-A (NZ)
Title: Two-step oxygen delignification of lignocellulosic pulp
Inventor: BOKSTROM MONICA
IPC: D21C9/10
Filed: 1996-09-18
Abstract: Methods for oxygen delignification of a pulp are disclosed, including initially delignifying the pulp at a delignification temperature of less than 90° C., adding oxygen to the pulp so that the oxygen is present during the initial delignification step, and further delignifying the pulp at a delignification temperature of greater than 90° C., the difference between the two delignification temperatures being less than about 20° C., and the pressure being greater in the initial delignification step. The method also includes adding alkali solely to the initial delignification step in order to obtain high alkalinity therein.
Patent NZ-330005-A (NZ)
Title: Injectable parasitidal compositions comprising ivermectin and a carrier of benzilic alcohol, polyvinyl pyrrolidone, n-methyl-2-pyrrolidone and glycerin
Inventor: LAMBERTI JORGE CARLOS
IPC: A61K31/7048
Filed: 1998-03-20
Abstract: Injectable, long acting parasiticidal composition which comprises enough ivermectin to achieve a final concentration of about 1% (w/w), benzilic alcohol, polyvinylpyrrolidone, N-metyl-2-pyrrolidone in a 40-65% proportion (v/w) of the total formulation and glycerin until completing final 100% weight. The process for its preparation involves mixing enough ivermectin to obtain a final concentration of about 1% (w/w) with benzilic alcohol and polyvinylpyrrolidone followed by the addition of the mixture to N-metyl-2-pyrrolidone, the latter in a 40-65% proportion (v/w) of the total of the formulation. The mixture is shaken until totally dissolved and glycerin is added until reaching 100% final weight.
Patent NZ-330316-A (NZ)
Title: Method and reagent for determining lipase in the presence of an carboxylic acid amide derivative by photometrically determining the amount of dye released from a lipase colour substrate
Inventor: SCHELLONG LIESELOTTE
IPC: C12Q1/44
Filed: 1997-09-16
Abstract: The invention concerns a method and reagent for the determination of lipase in the presence of a colour substrate and at least one N-substituted carboxylic acid amide derivative or a compound of the general formula (I) or (Ia)in which R1 and R2 independently of one another represent hydrogen or a saturated or unsaturated, substituted or unsubstituted hydrocarbon residue with 2 to 24 carbon atoms, Z denotes a saturated or unsaturated, substituted, cyclic or straight-chained hydrocarbon residue with 1 to 10 carbon atoms, X represents an atom or a group of atoms with positive charge and n is a number from 1 to 3. Tetra-sodium-N-(1,2-dicarboxylethyl)-N-alkylsulfosuccinamide or a mixture containing such a compound has proven to be particularly advantageous for the elimination of unspecific reactions in the determination of lipase in a biological sample.
Patent NZ-330941-A (NZ)
Title: A gas lighter comprising a safety ignition system
Inventor: ROGELET THIERRY
IPC: F23Q2/46
Filed: 1997-11-26
Abstract: This lighter (1) of the type comprising a reservoir for containing liquefied petroleum gas, a valve (3) mounted on the reservoir and permitting the gas to leave the same, a valve opening mechanism (4,5), as well as an ignition system comprising a flint (6) co-operating with a spark wheel (7) rotationally operated by at least one circular operating wheel (10) mounted co-axially with the spark wheel. This lighter is characterised in that each operating wheel is independent of the spark wheel and can pivot about its own axis independently of the spark wheel, and in that the axle is fixed to the spark wheel and comprises on its periphery zones which are concave and/or convex in transverse cross section, whereas the operating wheel comprises, in the region of its holes which enables its engagement on the axle, convex and/or concave zones, which are formed to slide with respect to the concave and/or convex zones of the axle when the force exercised on the operating wheel to ignite the lighter is below a threshold force, but engage with them when the force exercised is above the threshold force, and the largest cross sectional dimension of the axle is less than the smallest cross sectional dimension of die hole of the operating wheel, to permit the significant radial displacement of the operating wheel with respect to the axle and, below the said threshold force to permit the aid pivoting movement of the operating wheel with respect to the axle.
Patent NZ-333264-A (NZ)
Title: Chelates from macrocyclic polyaminocarboxylic acids with metal cations and their use in magnetic resonance imaging (MRI) for magnetic cations
Inventor: MEYER DOMINIQUE
IPC: C07F5/00
Filed: 1998-12-09
Abstract: Macrocyclic polyaminoacarboxylic acid chelates of the formula 1 where m is 1 or 2; R' is H, C1-4 alkyl or hydroxyalkyl, CH2COOH, CH2CONZ1Z2 Z1 and Z2 are H, or hydroxylated C1-4 alkyl group or R' is a group HOOC-CH-(CH2)m-CONHR where R is formula II a is I or 2 Z is a bond, CH2 Z' is a bond, O, S, NQ, CH2, CO, CO-NQ, NQ-CO, and more Z" is CO-NQ, NQ-CO and more R1, R2, R3, R4 and R5 are H, Br, Cl, I, CO- and more Q is H or optionally hydroxylated C1-4 alkyl. These chelates are used for diagnostic imaging like magnetic resonance imaging (MRI) for magnetic cations.
Patent NZ-500141-A (NZ)
Title: Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
Inventor: NEEDLEMAN PHILIP
IPC: A61K31/365
Filed: 1998-04-16
Abstract: The compound of formula I for the prevention of inflammation related cardiovascular disorders, providing the use of the compound of formula I is not in combination with a 5-lipoxygenase inhibitor, a leukotriene-A-hydrolase inhibitor or a leukotriene-B4-receptor antagonist. In the compound of formula I: A is selected from partially unsaturated or unsaturated heterocyclyl and partially unsaturated or unsaturated carbocyclic rings; R1 is selected from heterocyclyl, cycloalkyl, cycloalkenyl and aryl and is optionally substituted; R2 is a methyl or amino; R3 is a radical selected from hydrido, halo, alkyl, alkenyl, alkynyl, oxo, cyano, carboxyl, cyanoalkyl, heterocyclyloxy, alkyloxy, alkylthio, alkylcarbonyl, cycloalkyl, aryl, haloalkyl, heterocyclyl, cycloalkenyl, aralkyl, heterocyclylalkyl, acyl, alkylthioalkyl, hydroxyalkyl, alkoxycarbonyl, arylcarbonyl, aralkylcarbonyl, aralkenyl, alkoxyalkyl, arylthioalkyl, aryloxyalkyl, aralkylthioalkyl, aralkoxyalkyl, alkoxyaralkoxyalkyl, alkoxycarbonylalkyl, aminocarbonyl, aminocarbonylalkyl, alkylaminocarbonyl, N-arylaminocarbonyl, N-alkyl-N-arylaminocarbonyl, alkylaminocarbonylalkyl, carboxyalkyl, N-arylamino, N-aralkylamino, N-alkyl-N-aralkylamino, N-alkyl-N-arylamino, aminoalkyl, N-arylaminoalkyl, N-aralkylaminoalkyl, N-alkyl-N-aralkylaminoalkyl, N-alkyl-N-arylaminoalkyl, aryloxy, aralkoxy, arylthio, aralkylthio, alkylsulfinyl, alkylsulfonyl, aminosulfonyl, alkylaminosulfonyl, N-arylaminosulfonyl, arylsulfonyl, N-alkyl-N-arylaminosulfonyl. Providing that if A is imidazole, the sulfonylphenyl group is on the nitrogen atom that is the third ring atom, if A is pyrazole the sulfonylphenyl group is not substituted on a pyrazole ring nitrogen atom or the pyrazole ring carbon atom that is the fifth ring atom, if A is oxazole the sulfonylphenyl group is not substituted on the oxazole ring carbon atom that is the fifth ring atom, if A is isoxazole the sulfonylphenyl group is not substituted on the isoxazale ring carbon atom that is the third or fourth ring atom, if A is thiazole the sulfonylphenyl group is not substituted on the thiazole ring carbon that is the fourth or fifth ring atom.
Patent NZ-502076-A (NZ)
Title: Method for treating fibrous cellulosic materials to improve dye uptake
Inventor: BRODMANN GEORGE L
IPC: D06P5/13
Filed: 1998-06-02
Abstract: A method for changing the surface properties of a fibrous cellulose-containing material and dyeing the material.  The method comprises: (a) applying to at least one surface of the cellulose-containing material a cationic aqueous treating solution containing (1) a heterocyclic polyhydroxy compound selected from dimethyldihydroxy ethyleneurea, dimethyloldihydroxy ethyleneurea, trimethylol melamine, hexamethylol melamine and mixtures thereof, (2) choline chloride and (3) crosslinking catalyst to effect at least 60% wt. pickup of the treating solution onto the material, the concentration in the treating solution of heterocyclic polyhydroxy compound being 5-100 g/L, the concentration of choline chloride being 40-600 g/L and the weight ratio of heterocyclic polyhydroxy compound to choline chloride being 0.1-6; (b) heating the thusly treated cellulosic material from step (a) to a temperature of 250-315F (121-157C) to effect removal of water therefrom by evaporation, so that the water content is reduced to a level no higher than 1 % wt.; (c) further heating the dried material from step (b) to a temperature of 320-400F (169-240C) for 3-180 seconds to effect crosslinking of the cyclic polyhydroxy compound with the cellulose fibers in the material; (d) cooling the crosslinked cellulosic material; and (e) dyeing the crosslinked cellulosic material.
Patent NZ-503642-A (NZ)
Title: N1-[2,2-Dimethyl-1S-(pyridin-2-ylcarbamoyl)-propyl]-N4-hydroxy-2R-isobutyl-3S-methoxy-succinamide
Inventor: BECKETT RAYMOND PAUL
IPC: A61K31/44
Filed: 1997-11-13
Abstract: N1-[2,2-dimethyl-1S-(pyridin-2-ylcarbamoyl)-propyl]-N4-hydroxy-2R-isobutyl-3S-methoxy-succinamide of formula (II) or a pharmaceutically acceptable salt, hydrate or solvate thereof.  The compound is a metalloproteinase (MMP) inhibitor.  The compound may be used in the manufacture of a medicament for the treatment of rheumatoid arthritis, cancers, multiple sclerosis, Guillain-Barre syndrome or psoriasis.
Patent NZ-504418-A (NZ)
Title: Delayed release oral dosage form of carvedilol
Inventor: OH CHOON K
IPC: A61K47/32
Filed: 1998-11-12
Abstract: A matrix formulation containing carvedilol in an oral unit dosage form.
Patent NZ-509622-A (NZ)
Title: Peptides based on the sequence of human lactoferrin and their use
Inventor: MATTSBY-BALTZER INGER
IPC: A23J3/08
Filed: 1999-07-06
Abstract: Disclosed are new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof.  Also disclosed are medicinal products and foodstuffs, such as infant formula food, comprising such peptides, especially intended for treatment and prevention of infections or inflammations.  Specific examples include colitis, urinary tract infections, and candida infections on mucosal membranes.
Patent NZ-510279-A (NZ)
Title: Anchor for safety rope
Inventor: POLDMAA ARVO
IPC: A62B1/18
Filed: 1998-11-20
Abstract: Described is an anchor device (10) for a safety rope (8).  Anchor device (10) includes receiving means (12) for receiving the rope (8) and securing means (14, 16) for securing the receiving means (12) to a building's structure (39).  Also described is a building element which includes at least one mounting location for receiving the anchor device.
Patent NZ-511172-A (NZ)
Title: Buffered compositions for dialysis
Inventor: CALLAN ROBIN
IPC: A61K9/08
Filed: 1999-10-19
Abstract: Acid concentrates, and dialysate compositions prepared therefrom, containing citric acid and an effective amount of a buffering agent selected from acetate and/or lactate are disclosed, wherein the buffering agent allows a physiologically acceptable amount of citrate to maintain the desired pH of the dialysate.
Patent NZ-515584-A (NZ)
Title: Transfecting osteogenic precursor cells DNA encoding a LIM mineralization protein for a method of inducing bone formation
Inventor: BODEN SCOTT D
IPC: A61K35/76
Filed: 2000-04-28
Abstract: Described are isolated nucleic acid molecules that encode LIM mineralization protein, or LMP. Further described are vectors comprising splice variants of nucleotide sequences that encode LMP, as well as isolated host cells comprising those vectors. Moreover, medicaments for methods of inducing bone formation by transfecting osteogenic precursor cells with an isolated nucleic acid molecule comprising a nucleotide sequence encoding splice variants of LIM mineralization protein are provided. The transfection may occur ex vivo or in vitro by direct injection of virus or naked plasmid DNA. Described in particular is one method of fusing a spine by transfecting osteogenic precursor cells with an isolated nucleic acid molecule having a nucleotide sequence encoding LIM mineralization protein, admixing the transfected osteogenic precursor cells with a matrix and contacting the matrix with the spine. Finally, provided are methods for inducing systemic bone formation by stable transfection of host cells with the vectors described.
Patent NZ-515666-A (NZ)
Title: Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
Inventor: JINNO SHUJI
IPC: A61K31/31
Filed: 2000-06-02
Abstract: Compounds represented by general formula provided here, or pharmaceutically acceptable salts thereof. In said formula, X is CH, CH2, CHR (wherein R is lower alkyl or substituted lower alkyl), or CRR' (wherein R and R' are each as defined above as to R); Y is CH, CH2, or C=O; Z is O, S, S=O, or SO2; U is C or N; R1 to R4 are each independently hydrogen, OR, SR (wherein R is as defined above), an aromatic ring, a heterocycle, or the like; and at least one of R5 to R8 is OH. The compounds exhibit excellent pharmacological activities such as relaxation of tracheal smooth muscle, suppression of respiratory tract hypersensitiveness, and inhibition of phlogocytic infiltration into the respiratory tract.
Patent NZ-518991-A (NZ)
Title: A method for preventing or controlling the occurrence of stains on wood
Inventor: CARDOSO SARTORIO ROBERT
IPC: B27K5/00
Filed: 2000-10-27
Abstract: Method for treating wood in order to prevent or control the occurrence of stains such as sapwood stains, the method comprising a step of heating green wood in a moisture- saturated environment until the wood core temperature is in a range of about 60°C to 95°C, followed by a step of gradually cooling the wood, wherein the wood is maintained in an environment with moisture contents ranging from 95% to 100% during said cooling step.
Patent NZ-522805-A (NZ)
Title: Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
Inventor: MARLIERE PHILIPPE
IPC: A61K38/00
Filed: 2001-04-27
Abstract: Mutant prokaryotic cells are described, in particular E.coli, capable of producing proteins whereof the amino acid sequences comprise at least a non-conventional amino acid, methods for producing and purifying said proteins and the proteins obtained by the methods are also descried. Uses of the cells and proteins in different fields such as in therapy, cosmetics, diagnosis or biosynthesis or biodegradation of organic compounds are also provided.
Patent NZ-530527-A (NZ)
Title: Methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms
Inventor: LEENHOUTS CORNELIS JOHANNES
IPC: A61K38/00
Filed: 2002-06-11
Abstract: A method for obtaining cell-wall material of a Gram-positive bacterium with improved capacity for binding with a proteinaceous substances which comprises an AcmA cell-wall binding domain or a homolog or a functional derivative that binds to the cell-wall material. The method comprises treating the whole cell material with an acid and thus removing a cell-wall component and thus producing spherical peptidoglycan microparticles.
Patent NZ-536325-A (NZ)
Title: Needle-free medical connector with expandable valve mechanism and method of fluid flow control
Inventor: LEINSING KARL R
IPC: A61M39/04
Filed: 2003-05-05
Abstract: A needle-free medical connector (20) includes a housing (22) with a first port (28) and a second port (32). The connector also includes a piston element (38) defining a fluid passageway between the first and second ports. The piston element is movable between flow and non-flow positions. The piston element has an expandable section (56) having a variable inner width and volume that forms a part of the flow path through the connector. The expandable section includes an inner conduit (66) having a central bore (73), a plurality of radial slots (74) radiating outwards from the central bore. As the piston is compressed to the flow position, the expandable section is expanded in width by movement over a flow post (40) thereby maintaining or increasing the volume of the fluid passageway through the connector. The inner conduit is configured such that fluid may continuously flow through its entirety.
Patent NZ-537665-A (NZ)
Title: Aminoacetonitrile derivatives suitable for controlling parasites
Inventor: GOEBEL THOMAS
IPC: A61K31/275
Filed: 2003-06-18
Abstract: Compounds of the general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R8', R9, W, a, b and n have the significances given in claim 1, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
Patent NZ-539100-A (NZ)
Title: Process for production of biopolymers from nitrogen deficient wastewater
Inventor: REID NICOLA MAREE
Filed: 2000-11-20
Abstract: Disclosed herein is a process for producing biopolymers comprises passing nitrogen deficient wastewater through a treatment system comprising micro-organisms which grow aerobically in nitrogen deficient wastewater, and controlling the environment in the treatment system by maintaining a sufficiently stable dissolved oxygen level to thereby encourage the growth and/or biopolymer production activity of micro-organisms which produce the biopolymers, allowing the production of biomass and biopolymer, and recovering the produced biomass and the biopolymers. (62) Divided Out of 528556
Patent NZ-540315-A (NZ)
Title: Mobile wheel reconditioning facility
Inventor: MORRIS THOMAS E
IPC: B23P6/00
Filed: 2005-05-25
Abstract: A mobile enclosure 1 containing facilities for reconditioning automotive road wheels is disclosed. The enclosure houses a metal preparation station 12 and a wheel painting booth 10. The enclosure may be towed behind a vehicle. Other embodiments include further facilities such as a wheel straightening station or a wheel spinning station 11.
Patent NZ-540415-A (NZ)
Title: Use of levocetirizine for the treatment of persistent allergic rhinitis
Inventor: REVIRRON CHRISTOPHE
IPC: A61K31/495
Filed: 2003-05-26
Abstract: Disclosed is the use of levocetirizine or a pharmaceutically acceptable salt thereof for treating persistent allergic rhinitis, wherein the persistent allergic rhinitis comprises at least one symptom that persists more than 4 days per week, for more than 4 weeks, wherein the medicament is adapted for administration of a daily dosage from about 0.0005 mg to about 2 mg of said levocetirizine or said pharmaceutically acceptable salt thereof, per kg of body weight per patient, and wherein the medicament is administered during a period of equal or more than 3 months.
Patent NZ-541141-A (NZ)
Title: Phenol resin, use of a phenol resin as well as moulded product formed therefrom
Inventor: SCHUREN GERARDUS WILHELMUS
IPC: C08G8/20
Filed: 2004-01-15
Abstract: Disclosed is a phenol resin obtained by reacting phenolic compounds with formaldehyde and/or formaldehyde-forming compounds. The phenol resin has a polydispersity of maximally 1.85 and a weight average molecular weight (Mw) of maximally 600. Also disclosed are uses of the phenol resin with impregnation paper to form moulded products and moulded products formed therefrom.
Patent NZ-544088-A (NZ)
Title: Electronic security system for monitoring and recording activity and data relating to institutions and clients thereof
Inventor: SAJKOWSKY JAMES M
IPC: G07C9/00
Filed: 2004-06-17
Abstract: A tracking system for use in identifying individuals of a group, each of the individuals having an associated data set indicative of the identity of those individuals, includes an electromagnetic identification apparatus (20) configured with each of the individuals for providing an electromagnetic identification signal indicative of the content data set of that apparatus; a writer (22) for use in encoding the electromagnetic identification signals with signals indicative of the individual onto the electromagnetic identification apparatus (20); a controller (12) for receiving the encoded signals and for storing the encoded signals in a master database storage apparatus (14); and a reader (18) remotely positioned from the controller and configured for communicating with the electromagnetic identification apparatus (20) and receiving the encoded signals therefrom corresponding to the content data signal set, the reader also for providing the controller with signals indicative of the same.
Patent NZ-547858-A (NZ)
Title: Vertically movable window sash with unlatching element movable in direction of sash away from latched position
Inventor: BOOSEY MALCOLM DAVID
Filed: 2004-02-18
Abstract: A window sash has a self latching device with the latch member engaged in a strike in a frame portion. To release the latch an operating element is moved in the direction corresponding to the direction of movement of the sash away from the latched position. Typically relatively movable magnets are used to achieve the latching.
Patent NZ-565291-A (NZ)
Title: Power generation using immersed vessel(s) using off-peak electricity for pumping out water from vessel and to generate electricity via turbine during peak demand to feed to grid
Inventor: HASTINGS STEPHEN JOHN
IPC: F03B13/06
Filed: 2006-07-21
Abstract: A system for generating electricity for supply to a grid during periods of high tariff comprises an array of water-containing vessels immersed into a large body of water to a substantial depth with the lower end of the vessel spaced above the water bed. An inlet at the lower end of the vessel is associated with a valve whereby when the valve is closed water can be pumped out of the vessel using off-peak electricity. Water flowing into the vessel when the valve is opened drives a turbine within the vessel to generate electricity to be fed to the grid at peak pricing periods. In one embodiment each vessel is in the form of a tube suspended from fixed structure above the water level and immersed to a substantial depth, typically 60 metres or more. In other embodiments the vessels are in the form of floating vessels tethered relative to the water bed.